Mouse CD123-CAR T Cells Elicit Robust Anti-AML Activity without HSC Toxicity in Syngeneic Models

被引：0
|
作者：
Zoine, Jaquelyn T. [1 ]
Moore, Sarah E. [1 ]
Crawford, Jeremy C. [2 ]
Nevitt, Chris [1 ]
Langfitt, Deanna M. [1 ]
Barajas, Juan M. [3 ]
Abdelhamed, Sherif [3 ]
Iacobucci, Ilaria [3 ]
Michmerhuizen, Nicole L. [3 ]
Haydar, Dalia [1 ]
Krenciute, Giedre [1 ]
Mullighan, Charles G. [3 ]
Klco, Jeffery M. [3 ]
Gottschalk, Stephen [3 ]
Thomas, Paul G. [2 ]
Velasquez, M. Paulina [1 ]
机构：
[1] St Jude Childrens Res Hosp, Bone Marrow Transplant & Cellular Therapy, Memphis, TN USA
[2] St Jude Childrens Res Hosp, Immunol, Memphis, TN USA
[3] St Jude Childrens Res Hosp, Pathol, Memphis, TN USA
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
998
引用
收藏
页码：483 / 483
页数：1
相关论文
共 29 条
  • [1] Optimizing CD123-CAR T Cells for the Adoptive Immunotherapy of AML
    Riberdy, Janice
    Zhou, Sheng
    Zheng, Fei
    Hoehamer, Young-In Kim
    Moore, Jennifer
    Vaidya, Abishek
    Throm, Robert
    Ryu, Byoung
    Gottschalk, Stephen
    Velasquez, Mireya Paulina
    [J]. MOLECULAR THERAPY, 2019, 27 (04) : 271 - 272
  • [2] INDUCIBLE COSTIMULATION TO ENHANCE THE ANTI-AML ACTIVITY OF CD123-ENG T-CELLS
    Doherty, Erin
    Vaidya, Abishek
    Bonifant, Challice
    Mata, Melinda
    Leen, Ann
    Gottschalk, Stephen
    Velasquez, Paulina
    [J]. PEDIATRIC BLOOD & CANCER, 2018, 65
  • [3] Safety and Anti-Leukemic Activity of CD123-CAR T Cells in Pediatric Patients with AML: Preliminary Results from a Phase 1 Trial
    Naik, Swati
    Madden, Renee M.
    Lipsitt, Amanda
    Lockey, Timothy
    Bran, Jennyfer
    Rubnitz, Jeffrey E.
    Klco, Jeffery
    Shulkin, Barry
    Patil, Sagar L.
    Schell, Sarah
    Park, Jeoungeun John
    Riberdy, Janice
    Shang, Na
    Zoine, Jaquelyn T.
    Wallace, Jennifer
    Harstead, Elaine
    Willis, Catherine
    Metais, Jean-Yves
    Langfitt, Deanna M.
    Zhou, Sheng
    Akel, Salem M.
    Meagher, Michael M.
    Triplett, Brandon M.
    Gottschalk, Stephen
    Velasquez, Mireya Paulina
    [J]. BLOOD, 2022, 140 : 4584 - 4585
  • [4] CD70-Specific CAR T Cells Have Potent Activity Against Acute Myeloid Leukemia (AML) without HSC Toxicity
    Sauer, Tim
    Parikh, Kathan
    Sharma, Sandhya
    Omer, Bilal
    Gottschalk, Stephen
    Rooney, Cliona M.
    [J]. BLOOD, 2019, 134
  • [5] CD70-specific CAR T cells have potent activity against Acute Myeloid Leukemia (AML) without HSC toxicity
    Sauer, T.
    Parikh, K.
    Sharma, S.
    Omer, B.
    Angenendt, L.
    Schliemann, C.
    Schmitt, M.
    Mueller-Tidow, C.
    Gottschalk, S.
    Rooney, C. M.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 190 - 190
  • [6] Transgenic Expression of IL15 Retains CD123-Redirected T Cells in a Less Differentiated State Resulting in Improved Anti-AML Activity in Autologous AML PDX Models
    Mu-Mosley, Hong
    Ostermann, Lauren
    Muftuoglu, Muharrem
    Vaidya, Abishek
    Bonifant, Challice L.
    Velasquez, Mireya Paulina
    Gottschalk, Stephen
    Andreeff, Michael
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [7] CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity
    Sauer, Tim
    Parikh, Kathan
    Sharma, Sandhya
    Omer, Bilal
    Sedloev, David
    Chen, Qian
    Angenendt, Linus
    Schliemann, Christoph
    Schmitt, Michael
    Mueller-Tidow, Carsten
    Gottschalk, Stephen
    Rooney, Cliona M.
    [J]. BLOOD, 2021, 138 (04) : 318 - 330
  • [8] Treating Relapsed / Refractory (RR) AML with Biodegradable Anti-CD123 CAR Modified T Cells
    Cummins, Katherine D.
    Frey, Noelle
    Nelson, Anne Marie
    Schmidt, Aliza
    Luger, Selina
    Isaacs, Randi E.
    Lacey, Simon F.
    Hexner, Elizabeth
    Melenhorst, J. Joseph
    June, Carl H.
    Porter, David L.
    Gill, Saar I.
    [J]. BLOOD, 2017, 130
  • [9] High-affinity FRβ-specific CAR T cells eradicate AML and normal myeloid lineage without HSC toxicity
    R C Lynn
    Y Feng
    K Schutsky
    M Poussin
    A Kalota
    D S Dimitrov
    D J Powell Jr
    [J]. Leukemia, 2016, 30 : 1355 - 1364
  • [10] High-affinity FRβ-specific CAR T cells eradicate AML and normal myeloid lineage without HSC toxicity
    Lynn, R. C.
    Feng, Y.
    Schutsky, K.
    Poussin, M.
    Kalota, A.
    Dimitrov, D. S.
    Powell, D. J., Jr.
    [J]. LEUKEMIA, 2016, 30 (06) : 1355 - 1364
123